B-Cell Disorders and Curcumin
- PMID: 26674787
- PMCID: PMC5759937
- DOI: 10.1177/1534735415622013
B-Cell Disorders and Curcumin
Abstract
Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.
Keywords: curcumin; integrative medicine; monoclonal gammopathy of undetermined significance; smoldering myeloma; stage 0/1 chronic lymphocytic leukemia.
Conflict of interest statement
Similar articles
-
Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.Integr Cancer Ther. 2016 Jun;15(2):183-9. doi: 10.1177/1534735416635742. Epub 2016 May 6. Integr Cancer Ther. 2016. PMID: 27154182 Free PMC article.
-
Multitargeting by turmeric, the golden spice: From kitchen to clinic.Mol Nutr Food Res. 2013 Sep;57(9):1510-28. doi: 10.1002/mnfr.201100741. Epub 2012 Aug 13. Mol Nutr Food Res. 2013. PMID: 22887802 Review.
-
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.Am J Hematol. 2012 May;87(5):455-60. doi: 10.1002/ajh.23159. Epub 2012 Apr 4. Am J Hematol. 2012. PMID: 22473809 Clinical Trial.
-
Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.Clin Cancer Res. 2009 Feb 15;15(4):1123-5. doi: 10.1158/1078-0432.CCR-08-2791. Clin Cancer Res. 2009. PMID: 19228716 Free PMC article.
-
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22. Hematol Oncol Clin North Am. 2014. PMID: 25212882 Review.
Cited by
-
The Anti-Leukemic Activity of Natural Compounds.Molecules. 2021 May 5;26(9):2709. doi: 10.3390/molecules26092709. Molecules. 2021. PMID: 34063044 Free PMC article. Review.
-
Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.Curr Oncol Rep. 2017 Oct 14;19(12):79. doi: 10.1007/s11912-017-0635-0. Curr Oncol Rep. 2017. PMID: 29032389 Review.
-
Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.Biomolecules. 2021 Mar 7;11(3):392. doi: 10.3390/biom11030392. Biomolecules. 2021. PMID: 33800000 Free PMC article. Review.
-
Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review.Life (Basel). 2023 Jun 21;13(7):1422. doi: 10.3390/life13071422. Life (Basel). 2023. PMID: 37511797 Free PMC article. Review.
References
-
- Aggarwal BB, Kumar A, Aggarwal MS, Shisodia S. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Bagchi D, Preuss HG. eds. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton, FL: CRC Press; 2005:349-387.
-
- Beutler E, Lichtman MA, Coller BS, Kipps TJ. Williams Hematology. 5th ed. New York, NY: McGraw-Hill; 1995.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical